EP3730119A1 - Assembly for biopharmaceutical use comprising a bag and a frame - Google Patents
Assembly for biopharmaceutical use comprising a bag and a frame Download PDFInfo
- Publication number
- EP3730119A1 EP3730119A1 EP20170804.7A EP20170804A EP3730119A1 EP 3730119 A1 EP3730119 A1 EP 3730119A1 EP 20170804 A EP20170804 A EP 20170804A EP 3730119 A1 EP3730119 A1 EP 3730119A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- weld
- frame
- peripheral edge
- assembly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960000074 biopharmaceutical Drugs 0.000 title claims abstract description 29
- 229920002457 flexible plastic Polymers 0.000 claims abstract description 5
- 239000012530 fluid Substances 0.000 claims abstract description 5
- 230000002093 peripheral effect Effects 0.000 claims description 41
- 230000003014 reinforcing effect Effects 0.000 claims description 6
- -1 cell cultures Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 238000003466 welding Methods 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000021183 entrée Nutrition 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/16—Holders for containers
Definitions
- the invention relates to an assembly for biopharmaceutical use comprising a pocket suitable for receiving a biopharmaceutical product and a frame.
- biopharmaceutical product here means a product resulting from biotechnology, such as culture media, cell cultures, buffer solutions, artificial nutrition liquids, or a pharmaceutical product or more generally a product intended for use in the medical field. Such a product is in liquid, pasty or powdery form, in one or more phases, homogeneous or not, able to flow through a valve, thus being able to be qualified as fluid.
- the invention also applies to products other than biopharmaceuticals, according to the definition which has just been given, but which are subject to similar requirements as regards their storage or their treatment. Besides the transfer of a biopharmaceutical product, the bag can be adapted for a bioreactor or a fermenter.
- a bag receiving a biopharmaceutical product can for example be a single-use bag.
- a pocket can comprise two walls. The two walls are sealed with each other, for example by welding.
- this type of pouch is capable of expanding. Once expanded, the pouch has a limited volume. As a result, this type of pocket is commonly called a “2D pocket” (for “two dimensions”).
- a disposable pouch is usually made of a film. More precisely, the walls of the pocket include a multilayer film.
- the multilayer film comprises, for example, a contact layer, a barrier layer and an outer layer.
- the contact layer is intended to be in contact with the biopharmaceutical (in other words, the contact layer is on the volume side inside pocket).
- the contact layer is therefore made of a material compatible with the biopharmaceutical without causing degradation of the film or the biopharmaceutical.
- the material of the contact layer is generally selected from polyolefins such as, for example, polyethylene.
- the outer layer is intended to be in contact with the external environment.
- the outer layer contributes to the mechanical strength of the walls of the pocket. To this end, it must be flexible enough to withstand high mechanical stresses, but not be too stretchable in order to prevent any deformation of the bag when it is filled with a biopharmaceutical product.
- the barrier layer serves as a barrier to the passage of gases such as oxygen, carbon dioxide and is generally made of ethylene vinyl alcohol.
- the walls of the bag must be hermetically closed in order to avoid, for example, any product leakage outside the bag or any contamination of the product contained in the bag.
- the walls are generally welded to one another.
- the materials composing the multilayer film are sometimes hardly compatible in terms of soldering.
- the weld can give way, which leads to the loss of the integrity of the pocket.
- the weld can give way when too great a force is applied to the weld, when filling the bag with a biopharmaceutical product, or in the event of overfilling.
- the weld can also fail during transport or handling of the bag, in particular when the latter is filled with a biopharmaceutical product applying pressure to the weld.
- the invention improves the situation.
- a set for biopharmaceutical use comprising a pocket adapted to receive a biopharmaceutical product and a frame, the pocket being a flexible plastic envelope provided with at least one biopharmaceutical fluid inlet / outlet port and comprising a first side wall and a second side wall, the first side wall and the second side wall being partially secured by a weld, the weld defining a welded periphery of the pocket and delimiting an internal space of the pocket, the frame enclosing the pocket on a continuous path along of the welded periphery at least in one area of the weld.
- the frame thus makes it possible to overcome the problems of weld failure of the bag while maintaining its geometric characteristics and the materials of which it is made.
- the frame also makes it possible to reinforce the welding of the pocket, in particular when the pocket is made of materials that are difficult to match for welding together.
- the figure 1 illustrates an assembly 20 for biopharmaceutical use.
- the set includes a pocket 22 and a frame 24.
- Pocket 22 is illustrated in more detail on figure 2 .
- the pocket 22 is rectangular in shape and substantially flat, and extends along a plane P (visible for example at the figure 4 and at the figure 5 ).
- a pocket as illustrated is commonly referred to as a 2D pocket.
- the pocket 22 is a flexible plastic envelope.
- the pocket 22 includes an entry / exit port 27 and a first and a second side wall 28, 30.
- the flexible plastic envelope of the pocket 22 is for example composed of a multilayer film.
- the multilayer film can for example be composed of polyethylene.
- Polyethylene is particularly advantageous in terms of compatibility with the biopharmaceutical product intended to be contained in the bag 22.
- the pocket 22 is further provided with at least one input / output port 27.
- the input / output port 27 comprises a single orifice 26.
- the inlet / outlet port 27 may comprise several orifices (for example four) without, however, departing from the scope of the present invention.
- the inlet / outlet port 27 allows the passage of the biopharmaceutical fluid to the bag 22 or to leave it.
- the first side wall 28 and the second side wall 30 form the 2D shape of the pocket 22.
- the first side wall 28 and the second side wall 30 are joined by a weld 32.
- the inlet port / outlet 27 is secured to the first and to the second side wall 28, 30 by direct welding of a polyethylene part, such as for example a shuttle comprising at least the inlet / outlet port 27, with the first and second walls side 28, 30.
- Said input / output port being for example a connector with a tip of the fir type, often called "Hose Barb" in English.
- the inlet and outlet port 27 is a plastic (polyethylene, thermoplastic elastomeric polymer) or silicone tube secured directly by welding to the first and to the second side wall 28, 30 of the pocket. More specifically, due to the presence of the entry / exit port 27, the first side wall 28 and the second side wall 30 are not welded together in the region of the entry / exit port 27.
- the weld 32 defines a welded periphery 34 of the pocket 22. More precisely, the first side wall 28 and the second side wall 30 are welded together by the weld 32 along the welded periphery 34.
- the welded periphery 34 extends over the entire periphery of the pocket 22, that is to say over a continuous path all around the pocket 22.
- the weld 32 further defines an internal space 36 of the pocket 22.
- the internal space 36 is able to receive the biopharmaceutical product.
- the weld 32 comprises an internal peripheral edge 37 on the side of the internal space 36 of the pocket and an external peripheral edge 38 opposite the internal peripheral edge 37.
- the internal peripheral edge 37 delimits the internal space 36. of the pocket 22.
- the weld 32 is substantially flat between the outer peripheral edge 38 and the internal peripheral edge 37.
- the weld 32 extends in a radial direction R relative to the pocket 22.
- the weld 32 therefore extends radially from the internal space 36 away from it. More specifically, the radial direction R is located in the plane P, and extends perpendicularly to the tangent T of the internal peripheral edge 37, in the direction opposite to the internal space 36.
- the weld 32 includes a width L32.
- the width L32 is measured between the inner peripheral edge 37 and the outer peripheral edge 38. More precisely, the width L32 is measured in the radial direction R.
- the width L32 can be between 5 mm and 20 mm. For example, the width L32 is 10 mm.
- the figure 1 and the figure 3 illustrate an example of frame 24 according to the invention.
- the frame 24 is substantially flat and rectangular.
- the frame 24 is able to receive the pocket 22.
- the frame 24 constitutes a support for the pocket 22.
- the frame 24 applies a reinforcing pressure on the weld 32 of the pocket 22.
- the material of the frame 24 is chosen from so that the frame 24 does not deform when pressure is applied to the pocket 22, and in particular when the weld 32 of the pocket 22 is subjected to pressure. This pressure on the weld 32 may be due, for example, to the transport or handling of the bag 22, in particular when the latter is filled with a biopharmaceutical product. Therefore, the frame 24 is for example made of plastic.
- the frame 24 comprises a first part 40 and a second part 42.
- the first part 40 is able to come into contact with the first side wall 28 of the pocket 22.
- the second part 42 is able to come into contact with the second side wall. 30 of pocket 22.
- the first part 40 constitutes the upper face of the frame 24.
- the first part 40 is rectangular and planar.
- the first part 40 further comprises a rectangular recess 41 at its center. It is through this recess 41 that the pocket 22 can expand. More precisely, the shape of the first part 40 corresponds substantially to the shape of the weld 32 of the pocket 22.
- the first part 40 comprises an outer periphery 44 and an inner periphery 43.
- the outer periphery 44 is rectangular.
- the internal periphery 43 is rectangular and corresponds to the contour of the recess 41.
- the outer periphery 44 and the inner periphery 43 are spaced from each other by a width L40.
- the width L40 is between 1.2 times and 3 times the width of the weld L32.
- the width L40 represents 1.5 times the width L32.
- the width L40 is 20 mm.
- the second part 42 is illustrated in particular in figure 3 .
- the second part 42 constitutes the lower face of the frame 24.
- the second part 42 is rectangular and planar. More precisely, the second part 42 is in the form of a flat plate.
- the external shape of the second part 42 corresponds to the external shape of the first part 40. In other words, the external dimensions of the second part 42 and of the first part 40 are identical.
- the first part 40 and the second part 42 are fixed together by a fixing means 45 so as to apply a reinforcing pressure on the zone of the weld 32 in contact with the first part 40 and the second part 42.
- the pressure reinforcement applied by the fastening means 45 on the weld 32 is a prestress which must make it possible to prevent the weld 32 from failing.
- the applied prestress is between 10 N / m 2 and 100 N / m 2 . This prestress allows the weld 32 to withstand when the pocket 22 is subjected, for example, to a pressure in its internal space 36 up to 1.5 bars. This is for example the case when filling the bag 22 with a biopharmaceutical product.
- this prestress during filling makes it possible to protect the weld 32 from a possible rupture.
- the weld 32 is only really subjected to pressure during filling, it may be possible to remove the frame 24 which surrounds the bag 22, once the bag 22 has been filled.
- the frame 24 can therefore play a role of temporary reinforcement of the weld 32 when the pocket 22 is being filled.
- the frame 24 can play the role of support during use, transport and / or storage. pocket 22.
- the fixing means 45 may consist for example of screw-nut assemblies distributed over the periphery of the first part 40 and of the second part 42.
- the screw-nut assemblies in this case pass through the first part 40 and the second part 42 for join them together.
- the fixing means 45 is a set of rivets, distributed over the periphery of the first part 40 and of the second part 42.
- the fixing means 45 can be fixing lugs, preferably made of plastic or metal, engaging with the first part 40 and the second part 42. These tabs can in addition to include a tab for their placement around the first and second part 40, 42.
- the frame 24 surrounds the pocket 24 over the entire continuous path along the welded periphery 34.
- the frame 24 covers the entire width L32 of the weld 32.
- the width L40 of the first part 40 is greater than the width L32 so that the weld 32 is clamped between the first part 40 and the second part 42 of the frame 24.
- the frame 24 thus surrounds the weld 32 from the outer peripheral edge 38 towards the inner peripheral edge 37, over any width L32.
- the solder 32 is not exposed (that is to say not visible) in the recess 41.
- the edge of the internal peripheral 43 of the first part 40 faces the internal peripheral edge 37 of the weld 32.
- the edge of the internal periphery 43 of the first part 40 comes beyond the internal peripheral edge 37 of the weld 32.
- the weld 32 and a part of the pocket 22 directly in contact with the weld 32 is covered by the first part 40.
- the frame 24 not only crushes the weld 32 but also a part of the pocket 22.
- the width L40 may for example represent 1.5 times the width L32.
- the edge of the internal peripheral 43 of the first part 40 may for example extend beyond the weld 32, towards the internal space of the pocket 36, by 5 mm.
- the frame 24 encloses the pocket 24 over the entire continuous path along the welded periphery 34, but the frame 24 does not cover the entire width L32 of the weld 32.
- the frame 24 covers part of the width L32 of the weld.
- the frame 24 thus encloses the weld 32 from the outer peripheral edge 38 towards the inner peripheral edge 37, over part of the width L32.
- the weld 32 is partly exposed (i.e. visible) in the recess 41.
- the length L40 is chosen so that the first part 40 sufficiently covers the weld 32 so that the frame 24 sufficiently reinforces the weld 32 in the event of pressure applied to the weld 32.
- the figure 7 illustrates another exemplary embodiment of a frame 24 according to the invention.
- the first part 40 of the frame 24 comprises several recesses 41, so that the frame 24 can receive as many pockets 22 as the first part 40 comprises recess 41.
- the frame 24 receives six pockets 22. Each pocket 22 is arranged at a recess 41.
- the figure 8 illustrates another exemplary embodiment of a frame 24 according to the invention.
- the first part 40 and the second part 42 of the frame each comprise a recess 41. This alternative allows the inflation of the two side walls of the pocket 28, 30.
- the first part 40 and the second part 42 each comprise several recesses 41.
- Each recess 41 of the first part 40 is arranged opposite a recess 41 of the second part 42.
- This alternative makes it possible both to receive as many pockets 22 as the first part 40 or the second part 42 comprises a recess 41 and to allow the inflation of the two side walls 28, 30 of the pockets 22 held in the frame 24.
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Packages (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Bag Frames (AREA)
Abstract
Ensemble (20) à usage biopharmaceutique comprenant une poche (22) adaptée pour recevoir un produit biopharmaceutique et un cadre (24), la poche (22) étant une enveloppe plastique souple munie d'au moins un port d'entrée/sortie (27) de fluide biopharmaceutique et comprenant une première paroi latérale (28) et une deuxième paroi latérale (30), la première paroi latérale (28) et la deuxième paroi latérale (30) étant en partie solidarisées par une soudure (32), la soudure (32) définissant un pourtour soudé (34) de la poche (22) et délimitant un espace interne (36) de la poche (22), le cadre (24) enserrant la poche (22) sur un parcours continu le long du pourtour soudé (34) au moins dans une zone de la soudure (32).Set (20) for biopharmaceutical use comprising a bag (22) adapted to receive a biopharmaceutical product and a frame (24), the bag (22) being a flexible plastic envelope provided with at least one input / output port (27 ) of biopharmaceutical fluid and comprising a first side wall (28) and a second side wall (30), the first side wall (28) and the second side wall (30) being in part secured by a weld (32), the weld (32) defining a welded periphery (34) of the pocket (22) and delimiting an internal space (36) of the pocket (22), the frame (24) enclosing the pocket (22) on a continuous path along the periphery welded (34) at least in one area of the weld (32).
Description
L'invention est relative à un ensemble à usage biopharmaceutique comprenant une poche adaptée pour recevoir un produit biopharmaceutique et un cadre.The invention relates to an assembly for biopharmaceutical use comprising a pocket suitable for receiving a biopharmaceutical product and a frame.
On entend ici par produit biopharmaceutique un produit issu de la biotechnologie, tels que milieux de cultures, cultures cellulaires, solutions tampon, liquides de nutrition artificielle, ou un produit pharmaceutique ou plus généralement un produit destiné à être utilisé dans le domaine médical. Un tel produit est sous forme liquide, pâteuse, poudreuse, en une ou plusieurs phases, homogènes ou non, apte à s'écouler à travers une valve, pouvant ainsi être qualifié de fluide. L'invention s'applique également à des produits autres que biopharmaceutiques, selon la définition qui vient d'en être donnée, mais qui sont soumis à des exigences analogues en ce qui concerne leur stockage ou leur traitement. Outre le transfert d'un produit biopharmaceutique, la poche peut être adaptée pour un bioréacteur ou un fermenteur.The term “biopharmaceutical product” here means a product resulting from biotechnology, such as culture media, cell cultures, buffer solutions, artificial nutrition liquids, or a pharmaceutical product or more generally a product intended for use in the medical field. Such a product is in liquid, pasty or powdery form, in one or more phases, homogeneous or not, able to flow through a valve, thus being able to be qualified as fluid. The invention also applies to products other than biopharmaceuticals, according to the definition which has just been given, but which are subject to similar requirements as regards their storage or their treatment. Besides the transfer of a biopharmaceutical product, the bag can be adapted for a bioreactor or a fermenter.
Une poche recevant un produit biopharmaceutique peut par exemple être une poche à usage unique. Une telle poche peut comprendre deux parois. Les deux parois sont scellées l'une avec l'autre, par exemple par une soudure. Afin de recevoir le produit biopharmaceutique, ce type de poche est capable de s'expanser. Une fois expansée, la poche a un volume limité. De ce fait, ce type de poche est communément appelé « poche 2D » (pour « deux dimensions »).A bag receiving a biopharmaceutical product can for example be a single-use bag. Such a pocket can comprise two walls. The two walls are sealed with each other, for example by welding. In order to receive the biopharmaceutical product, this type of pouch is capable of expanding. Once expanded, the pouch has a limited volume. As a result, this type of pocket is commonly called a “2D pocket” (for “two dimensions”).
Une poche à usage unique est généralement composée d'un film. Plus précisément, les parois de la poche comprennent un film multicouche. Le film multicouche comprend par exemple une couche de contact, une couche barrière et une couche externe.A disposable pouch is usually made of a film. More precisely, the walls of the pocket include a multilayer film. The multilayer film comprises, for example, a contact layer, a barrier layer and an outer layer.
La couche de contact est destinée à être en contact avec le produit biopharmaceutique (en d'autres termes, la couche de contact est du côté du volume interne de la poche). La couche de contact est par conséquent faite d'un matériau compatible avec le produit biopharmaceutique sans provoquer de dégradation du film ou du produit biopharmaceutique. A cet effet, le matériau de la couche de contact est généralement sélectionné parmi les polyoléfines tels que par exemple le polyéthylène.The contact layer is intended to be in contact with the biopharmaceutical (in other words, the contact layer is on the volume side inside pocket). The contact layer is therefore made of a material compatible with the biopharmaceutical without causing degradation of the film or the biopharmaceutical. For this purpose, the material of the contact layer is generally selected from polyolefins such as, for example, polyethylene.
La couche externe est destinée à être en contact avec l'environnement extérieur. La couche externe contribue à la résistance mécanique des parois de la poche. À cette fin, elle doit être suffisamment souple pour supporter des contraintes mécaniques élevées, mais ne pas être trop extensible afin d'empêcher toute déformation de la poche lorsqu'elle est remplie avec un produit biopharmaceutique.The outer layer is intended to be in contact with the external environment. The outer layer contributes to the mechanical strength of the walls of the pocket. To this end, it must be flexible enough to withstand high mechanical stresses, but not be too stretchable in order to prevent any deformation of the bag when it is filled with a biopharmaceutical product.
La couche barrière sert de barrière au passage de gaz tels que l'oxygène, le dioxyde de carbone et est généralement constituée d'éthylène-alcool vinylique.The barrier layer serves as a barrier to the passage of gases such as oxygen, carbon dioxide and is generally made of ethylene vinyl alcohol.
Les parois de la poche doivent être fermées hermétiquement afin d'éviter par exemple toute fuite de produit en dehors de la poche ou toute contamination du produit contenu dans la poche. A cet effet, les parois sont généralement soudées l'une avec l'autre. Cependant, les matériaux composant le film multicouche sont parfois difficilement compatibles en termes de soudure. Ainsi, dans certaines situations, la soudure peut céder, ce qui entraine la perte de l'intégrité de la poche. Par exemple, la soudure peut céder lorsque des efforts trop importants sont appliqués sur la soudure, lors du remplissage de la poche par un produit biopharmaceutique, ou en cas de sur-remplissage. La soudure peut également céder lors du transport ou de la manipulation de la poche, notamment lorsque celle-ci est emplie d'un produit biopharmaceutique appliquant une pression sur la soudure.The walls of the bag must be hermetically closed in order to avoid, for example, any product leakage outside the bag or any contamination of the product contained in the bag. For this purpose, the walls are generally welded to one another. However, the materials composing the multilayer film are sometimes hardly compatible in terms of soldering. Thus, in certain situations, the weld can give way, which leads to the loss of the integrity of the pocket. For example, the weld can give way when too great a force is applied to the weld, when filling the bag with a biopharmaceutical product, or in the event of overfilling. The weld can also fail during transport or handling of the bag, in particular when the latter is filled with a biopharmaceutical product applying pressure to the weld.
L'invention vient améliorer la situation.The invention improves the situation.
Il est proposé un ensemble à usage biopharmaceutique comprenant une poche adaptée pour recevoir un produit biopharmaceutique et un cadre, la poche étant une enveloppe plastique souple munie d'au moins un port d'entrée/sortie de fluide biopharmaceutique et comprenant une première paroi latérale et une deuxième paroi latérale, la première paroi latérale et la deuxième paroi latérale étant en partie solidarisées par une soudure, la soudure définissant un pourtour soudé de la poche et délimitant un espace interne de la poche, le cadre enserrant la poche sur un parcours continu le long du pourtour soudé au moins dans une zone de la soudure.There is proposed a set for biopharmaceutical use comprising a pocket adapted to receive a biopharmaceutical product and a frame, the pocket being a flexible plastic envelope provided with at least one biopharmaceutical fluid inlet / outlet port and comprising a first side wall and a second side wall, the first side wall and the second side wall being partially secured by a weld, the weld defining a welded periphery of the pocket and delimiting an internal space of the pocket, the frame enclosing the pocket on a continuous path along of the welded periphery at least in one area of the weld.
Le cadre permet ainsi de palier les problèmes de rupture de soudure de la poche tout en conservant ses caractéristiques géométriques et les matériaux qui la composent. Le cadre permet en outre de renforcer la soudure de la poche notamment lorsque la poche est composée de matériaux difficilement compatibles pour une soudure entre-eux.The frame thus makes it possible to overcome the problems of weld failure of the bag while maintaining its geometric characteristics and the materials of which it is made. The frame also makes it possible to reinforce the welding of the pocket, in particular when the pocket is made of materials that are difficult to match for welding together.
L'ensemble peut en outre comprendre les caractéristiques exposées dans les paragraphes suivants qui peuvent, optionnellement, être mises en œuvre indépendamment les unes des autres ou en combinaison les unes avec les autres :
- la poche est fermée par la soudure à l'exception de la zone comprenant le au moins un port d'entrée/sortie, et le cadre enserre la poche sur la totalité du parcours continu le long du pourtour soudé ;
- le cadre comprend une première partie apte à venir en contact avec la première paroi latérale et une deuxième partie apte à venir en contact avec la deuxième paroi latérale, la première partie et la deuxième partie étant fixées entre-elles par un moyen de fixation de sorte à appliquer une pression de renfort sur la soudure;
- la pression de renfort appliquée sur la soudure est comprise entre 10 N/m2 et 100 N/m2;
- la première partie du cadre comprend un évidement et la deuxième partie du cadre comprend une plaque plane de sorte que le cadre encadre la poche ;
- l'ensemble comprend plusieurs poches et la première partie du cadre comprend plusieurs évidements, chaque évidement étant apte à recevoir une des poches ;
- la soudure s'étend selon une direction radiale par rapport à la poche ;
- la soudure comprend un bord périphérique interne du côté de l'espace interne de la poche et un bord périphérique externe opposé au bord périphérique interne, la soudure étant sensiblement plate entre le bord périphérique interne et le bord périphérique externe ;
- la soudure comprend une largeur mesurée entre le bord périphérique interne et le bord périphérique externe, la largeur étant comprise entre 5 et 20 mm ;
- le cadre enserre la soudure depuis le bord périphérique interne vers le bord périphérique externe, sur une partie de la largeur;
- la première partie comprend une périphérie externe et une périphérie interne, la périphérie externe et la périphérie interne étant espacées l'une de l'autre par une largeur, la largeur représentant 1,5 fois la largeur de la soudure;
- le cadre enserre la soudure depuis le bord périphérique interne vers le bord périphérique externe sur toute la largeur ;
- le cadre enserre en outre une partie de la poche au-delà de la soudure.
- the pocket is closed by the weld except for the area comprising the at least one entry / exit port, and the frame surrounds the pocket over the entire continuous path along the welded periphery;
- the frame comprises a first part adapted to come into contact with the first side wall and a second part adapted to come into contact with the second side wall, the first part and the second part being fixed together by a fixing means so applying reinforcing pressure to the weld;
- the reinforcing pressure applied to the weld is between 10 N / m 2 and 100 N / m 2 ;
- the first part of the frame comprises a recess and the second part of the frame comprises a planar plate so that the frame frames the pocket;
- the assembly comprises several pockets and the first part of the frame comprises several recesses, each recess being able to receive one of the pockets;
- the weld extends in a radial direction relative to the pocket;
- the weld comprises an internal peripheral edge on the side of the internal space of the pocket and an external peripheral edge opposite the internal peripheral edge, the weld being substantially flat between the internal peripheral edge and the external peripheral edge;
- the weld comprises a width measured between the inner peripheral edge and the outer peripheral edge, the width being between 5 and 20 mm;
- the frame encloses the weld from the inner peripheral edge to the outer peripheral edge, over part of the width;
- the first part comprises an outer periphery and an inner periphery, the outer periphery and the inner periphery being spaced apart from each other by a width, the width being 1.5 times the width of the weld;
- the frame encloses the weld from the inner peripheral edge to the outer peripheral edge over the entire width;
- the frame further encloses part of the pocket beyond the weld.
D'autres caractéristiques, détails et avantages de l'invention apparaîtront à la lecture de la description détaillée ci-après, et à l'analyse des dessins annexés, sur lesquels :
-
Fig. 1
[Fig. 1 ] montre un ensemble vue de dessus selon un mode de réalisation de l'invention ; -
Fig. 2
[Fig. 2 ] montre une poche vue de dessus selon un mode de réalisation de l'invention ; -
Fig. 3
[Fig. 3 ] montre l'ensemble de lafigure 1 vue de dessous ; -
Fig. 4
[Fig. 4 ] montre l'ensemble dans une vue en coupe selon le plan A de lafigure 1 ; -
Fig. 5
[Fig. 5 ] montre un exemple de l'ensemble dans une vue en coupe selon le plan B de lafigure 1 ; -
Fig. 6
[Fig. 6 ] montre un autre exemple de l'ensemble dans une vue en coupe selon le plan B de lafigure 1 ; -
Fig. 7
[Fig. 7 ] montre un ensemble vue de dessus selon un autre mode de réalisation de l'invention ; -
Fig. 8
[Fig. 8 ] montre un ensemble dans une vue en coupe selon un autre mode de réalisation de l'invention. -
Fig. 9
[Fig. 9 ] montre un ensemble dans une vue en coupe selon un autre mode de réalisation de l'invention.
-
Fig. 1
[Fig. 1 ] shows a top view assembly according to one embodiment of the invention; -
Fig. 2
[Fig. 2 ] shows a top view pocket according to one embodiment of the invention; -
Fig. 3
[Fig. 3 ] shows the wholefigure 1 view from below; -
Fig. 4
[Fig. 4 ] shows the assembly in a sectional view along plane A of thefigure 1 ; -
Fig. 5
[Fig. 5 ] shows an example of the assembly in a sectional view along plane B of thefigure 1 ; -
Fig. 6
[Fig. 6 ] shows another example of the assembly in a sectional view along plane B of thefigure 1 ; -
Fig. 7
[Fig. 7 ] shows a top view assembly according to another embodiment of the invention; -
Fig. 8
[Fig. 8 ] shows an assembly in a sectional view according to another embodiment of the invention. -
Fig. 9
[Fig. 9 ] shows an assembly in a sectional view according to another embodiment of the invention.
Les dessins et la description ci-après contiennent, pour l'essentiel, des éléments de caractère certain. Ils pourront donc non seulement servir à mieux faire comprendre la présente invention, mais aussi contribuer à sa définition, le cas échéant.The drawings and the description below essentially contain elements of a certain nature. They can therefore not only serve to better understand the present invention, but also contribute to its definition, if necessary.
La
La poche 22 est illustrée de façon plus détaillée à la
L'enveloppe plastique souple de la poche 22 est par exemple composée d'un film multicouche. Le film multicouche peut par exemple être composé de polyéthylène. Le polyéthylène est particulièrement avantageux en termes de compatibilité avec le produit biopharmaceutique destiné à être contenu dans la poche 22.The flexible plastic envelope of the
La poche 22 est en outre munie d'au moins un port d'entrée/sortie 27. Par exemple, tel qu'illustré, le port d'entrée/sortie 27 comprend un seul orifice 26. Selon d'autres exemples non illustrés, le port d'entrée/sortie 27 peut comprendre plusieurs orifices (par exemple quatre) sans toutefois sortir du domaine de la présente invention. Le port d'entrée/sortie 27 permet le passage du fluide biopharmaceutique vers la poche 22 ou d'en sortir.The
La première paroi latérale 28 et la deuxième paroi latérale 30 forment la forme 2D de la poche 22. La première paroi latérale 28 et la deuxième paroi latérale 30 sont solidarisées par une soudure 32. En outre, selon une variante, le port d'entrée/sortie 27 est solidarisé à la première et à la deuxième paroi latérale 28, 30 par soudure directe d'une pièce en polyéthylène, comme par exemple une navette comportant au moins le port d'entrée/sortie 27, avec les première et deuxième parois latérales 28, 30. Ledit port d'entrée/sortie étant par exemple un connecteur avec un embout de type sapin, souvent appelée « Hose Barb » en anglais. Selon une autre variante, le port d'entrée sortie 27 est un tube en matière plastique (polyéthylène, polymère élastomère thermoplastique) ou silicone solidarisé directement par soudure à la première et à la deuxième paroi latérale 28, 30 de la poche. Plus précisément, en raison de la présence du port d'entrée/sortie 27, la première paroi latérale 28 et la deuxième paroi latérale 30 ne sont pas soudées entre-elles dans la région du port d'entrée/sortie 27. La soudure 32 définit un pourtour soudé 34 de la poche 22. Plus précisément, la première paroi latérale 28 et la deuxième paroi latérale 30 sont soudées entre-elles par la soudure 32 le long du pourtour soudé 34. Comme visible sur la
La soudure 32 comprend un bord périphérique interne 37 du côté de l'espace interne 36 de la poche et un bord périphérique externe 38 opposé au bord périphérique interne 37. En d'autres termes, le bord périphérique interne 37 délimite l'espace interne 36 de la poche 22. La soudure 32 est sensiblement plate entre le bord périphérique externe 38 et le bord périphérique interne 37. La soudure 32 s'étend selon une direction radiale R par rapport à la poche 22. La soudure 32 s'étend donc radialement depuis l'espace interne 36 en s'éloignant de celui-ci. Plus précisément, la direction radiale R se situe dans le plan P, et s'étend perpendiculairement à la tangente T du bord périphérique interne 37, dans la direction opposée à l'espace interne 36.The
En outre, la soudure 32 comprend une largeur L32. La largeur L32 est mesurée entre le bord périphérique interne 37 et le bord périphérique externe 38. Plus précisément, la largeur L32 est mesurée selon la direction radiale R. La largeur L32 peut être comprise entre 5 mm et 20 mm. Par exemple, la largeur L32 est de 10 mm.Further, the
La
Le cadre 24 comprend une première partie 40 et une deuxième partie 42. La première partie 40 est apte à venir en contact avec la première paroi latérale 28 de la poche 22. La deuxième partie 42 est apte à venir en contact avec la deuxième paroi latérale 30 de la poche 22.The
La première partie 40 constitue la face supérieure du cadre 24. La première partie 40 est rectangulaire et plane. La première partie 40 comprend en outre un évidement 41 rectangulaire en son centre. C'est par cet évidement 41 que pourra s'expanser la poche 22. Plus précisément, la forme de la première partie 40 correspond sensiblement à la forme de la soudure 32 de la poche 22. Comme visible à la
La deuxième partie 42 est illustrée notamment à la
La première partie 40 et la deuxième partie 42 sont fixées entre-elles par un moyen de fixation 45 de sorte à appliquer une pression de renfort sur la zone de la soudure 32 en contact avec la première partie 40 et la deuxième partie 42. La pression de renfort appliquée par le moyen de fixation 45 sur la soudure 32 est une précontrainte qui doit permettre d'empêcher la soudure 32 de céder. Par exemple, la précontrainte appliquée est comprise entre 10 N/m2 et 100 N/m2. Cette précontrainte permet à la soudure 32 de résister lorsque la poche 22 est soumise par exemple à une pression dans son espace interne 36 jusqu'à 1,5 Bars. Ceci est par exemple le cas lors du remplissage de la poche 22 par un produit biopharmaceutique. L'application de cette précontrainte lors du remplissage permet de protéger la soudure 32 d'une éventuelle rupture. La soudure 32 n'étant réellement soumise à une pression que lors du remplissage, il peut être possible de retirer le cadre 24 qui enserre la poche 22, une fois la poche 22 remplie. Le cadre 24 peut donc jouer un rôle de renfort temporaire de la soudure 32 au moment du remplissage de la poche 22. Alternativement ou au surplus, la cadre 24 peut jouer le rôle de support durant l'utilisation, le transport et/ou le stockage de la poche 22.The
Le moyen de fixation 45 peut consister par exemple par des ensembles vis-écrous répartis sur la périphérie de la première partie 40 et de la deuxième partie 42. Les ensembles vis-écrous traversent dans ce cas la première partie 40 et la deuxième partie 42 pour les joindre entre-elles. Selon un autre exemple, le moyen de fixation 45 est un ensemble de rivets, répartis sur la périphérie de la première partie 40 et de la deuxième partie 42. Alternativement, le moyen de fixation 45 peut être des pattes de fixation, préférentiellement en plastique ou en métal, venant en prise avec la première partie 40 et la deuxième partie 42. Ces pattes peuvent en outre comprendre une languette pour leur mise en place autour des première et deuxième partie 40, 42.The fixing means 45 may consist for example of screw-nut assemblies distributed over the periphery of the
Selon l'exemple visible à la
Selon un autre exemple, visible à la
La
La
Selon un autre exemple de réalisation conforme à l'invention, la première partie 40 et la deuxième partie 42 comprennent chacune plusieurs évidements 41. Chaque évidement 41 de la première partie 40 est agencé en regard d'un évidement 41 de la deuxième partie 42. Cette alternative permet à la fois de recevoir autant de poche 22 que la première partie 40 ou la deuxième partie 42 comprend d'évidement 41 et de permettre le gonflement des deux parois latérales 28, 30 des poches 22 maintenues dans le cadre 24.According to another exemplary embodiment according to the invention, the
- - 20 : ensemble- 20: set
- - 22 : poche- 22: pocket
- - 24 : cadre- 24: frame
- - 26 : orifice- 26: orifice
- - 27 : port d'entrée/sortie- 27: input / output port
- - 28 : première paroi latérale- 28: first side wall
- - 30 : deuxième paroi latérale- 30: second side wall
- - 32 : soudure- 32: welding
- - 34 : pourtour- 34: circumference
- - 36 : espace interne- 36: internal space
- - 37 : bord périphérique interne- 37: internal peripheral edge
- - 38 : bord périphérique externe- 38: outer peripheral edge
- - 40 : première partie du cadre- 40: first part of the frame
- - 41 : évidement- 41: obviously
- - 42 : deuxième partie du cadre- 42: second part of the frame
- - 43 : périphérie interne de la première partie du cadre- 43: internal periphery of the first part of the frame
- - 44 : périphérie externe de la première partie du cadre- 44: outer periphery of the first part of the frame
- - 45 : moyen de fixation- 45: fixing means
- - L32 : largeur de la soudure- L32: width of the weld
- - L40 : largeur du bord de la première partie du cadre- L40: width of the edge of the first part of the frame
- - R : direction radiale- R: radial direction
- - T : tangente- T: tangent
Claims (11)
dans lequel le cadre (24)
in which the frame (24)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1904470A FR3095337B1 (en) | 2019-04-26 | 2019-04-26 | SET FOR BIOPHARMACEUTICAL USE INCLUDING A POCKET AND A FRAME |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3730119A1 true EP3730119A1 (en) | 2020-10-28 |
EP3730119B1 EP3730119B1 (en) | 2023-05-03 |
Family
ID=68210896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20170804.7A Active EP3730119B1 (en) | 2019-04-26 | 2020-04-22 | Assembly for biopharmaceutical use comprising a bag and a frame |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3730119B1 (en) |
FR (1) | FR3095337B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11709156B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved analytical analysis |
US11709155B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
US11918936B2 (en) | 2020-01-17 | 2024-03-05 | Waters Technologies Corporation | Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007103917A2 (en) * | 2006-03-06 | 2007-09-13 | Integrated Biosystems, Inc. | Systems and methods for freezing, storing and thawing biopharmaceutical materials |
US20130341354A1 (en) * | 2012-06-26 | 2013-12-26 | Gojo Industries, Inc. | Portable liquid dispenser |
US20180125756A1 (en) * | 2016-11-04 | 2018-05-10 | Corning Incorporated | Glass bio-containers and methods for manufacturing the same |
-
2019
- 2019-04-26 FR FR1904470A patent/FR3095337B1/en active Active
-
2020
- 2020-04-22 EP EP20170804.7A patent/EP3730119B1/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007103917A2 (en) * | 2006-03-06 | 2007-09-13 | Integrated Biosystems, Inc. | Systems and methods for freezing, storing and thawing biopharmaceutical materials |
US20130341354A1 (en) * | 2012-06-26 | 2013-12-26 | Gojo Industries, Inc. | Portable liquid dispenser |
US20180125756A1 (en) * | 2016-11-04 | 2018-05-10 | Corning Incorporated | Glass bio-containers and methods for manufacturing the same |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11709156B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved analytical analysis |
US11709155B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
US11918936B2 (en) | 2020-01-17 | 2024-03-05 | Waters Technologies Corporation | Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding |
Also Published As
Publication number | Publication date |
---|---|
FR3095337B1 (en) | 2021-05-28 |
FR3095337A1 (en) | 2020-10-30 |
EP3730119B1 (en) | 2023-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3730119B1 (en) | Assembly for biopharmaceutical use comprising a bag and a frame | |
BE1009817A3 (en) | Stamps for packaging of application of skin. | |
EP2694401B1 (en) | Ring for a device for dispensing a fluid product | |
EP3393660B1 (en) | Method for manufacturing a sealed container | |
EP3364479A1 (en) | Battery, in particular a button cell, and method for manufacturing same | |
CH694076A5 (en) | protection system against overfilling for implantable devices for drug delivery. | |
WO2000004131A1 (en) | Flexible bags for transporting biopharmaceutical fluid products | |
FR3003245A1 (en) | RECEPTION, VIDAGE AND PRESSURE TRANSFER OF A LARGE QUANTITY OF BIOPHARMACEUTICAL FLUID FOR SUBSEQUENT TREATMENT. | |
EP2577144B1 (en) | Joint with communication between biopharmaceutical containers and/or conduits | |
EP3268291A1 (en) | Device for conveying a bag comprising a biopharmaceutical fluid and systems and a method using same | |
FR2978225A1 (en) | VALVE OPERATING SELECTIVE FOR A CONTAINER FOR BIOPHARMACEUTICAL USE. | |
WO2021053237A1 (en) | One-piece connector for a flexible infusion bag | |
EP2999450B1 (en) | Stopper of a connector for an infusion bag | |
WO2010102990A1 (en) | Casing for storing used nuclear fuel with easy closing | |
EP4153506A1 (en) | Leaktight container having a flexible wall comprising a fixing ring for joining it to a device allowing the container to be removably connected to an enclosure | |
FR3102698A1 (en) | WATERPROOF CONTAINER INCLUDING A DEVICE ALLOWING REMOVABLE CONNECTION TO A SPEAKER | |
EP2193086B1 (en) | Flexible transport container and production method thereof | |
WO2023111303A1 (en) | Leak-tight container comprising a two-layer leak-tight reinforcing strip | |
FR3102823A1 (en) | Watertight junction device between two containment enclosures offering improved watertightness | |
WO2018091809A1 (en) | Medical bag with two compartments and including a tab | |
FR3063990A1 (en) | MICRO-FLUIDIC DEVICE | |
JP2006255378A (en) | Small capacity container | |
EP0522934A1 (en) | Saddle connection for a pipe and assembly composed of that saddle connector and pipe | |
WO2021170916A1 (en) | Pocket refill comprising means for degassing the pocket and dispenser casing comprising such a pocket refill | |
EP0084512A1 (en) | Sterile Siamese bag |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210413 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20230206 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1563983 Country of ref document: AT Kind code of ref document: T Effective date: 20230515 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602020010274 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230526 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20230503 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1563983 Country of ref document: AT Kind code of ref document: T Effective date: 20230503 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230904 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230803 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230903 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230804 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602020010274 Country of ref document: DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20240206 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230503 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240418 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240419 Year of fee payment: 5 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602020010274 Country of ref document: DE Owner name: SARTORIUS STEDIM, FR Free format text: FORMER OWNER: SARTORIUS STEDIM FMT SAS, AUBAGNE, FR |